| 18.73 -0.22 (-1.16%) | 09-18 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 22.27 |
1-year : | 23.04 |
| Resists | First : | 19.07 |
Second : | 19.72 |
| Pivot price | 18.78 |
|||
| Supports | First : | 18.01 |
Second : | 14.98 |
| MAs | MA(5) : | 18.9  |
MA(20) : | 18.95 |
| MA(100) : | 17.3 |
MA(250) : | 16.76 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 58.6 |
D(3) : | 58.5 |
| RSI | RSI(14): 49.7 |
|||
| 52-week | High : | 19.85 | Low : | 13.09 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SHC ] has closed above bottom band by 45.5%. Bollinger Bands are 19.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 19.02 - 19.13 | 19.13 - 19.21 |
| Low: | 18.41 - 18.54 | 18.54 - 18.65 |
| Close: | 18.53 - 18.73 | 18.73 - 18.9 |
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
Fri, 18 Sep 2026
Sotera Health: Pricing Power And Recurring Revenues Are Growth Drivers (NASDAQ:SHC) - Seeking Alpha
Thu, 17 Sep 2026
Will Earnings Beat Change Sotera Health (SHC) Narrative - simplywall.st
Tue, 15 Sep 2026
Here’s Why Sotera Health Company (SHC) Surged after Q2 Report - AlphaStreet
Tue, 15 Sep 2026
Here’s Why Sotera Health Company (SHC) Surges 25% in Q2 - Yahoo Finance
Tue, 08 Sep 2026
Piper Sandler Maintains Sotera Health Company(SHC.US) With Buy Rating, Maintains Target Price $25 - Moomoo
Wed, 12 Aug 2026
Sotera Health Company’s Q2 Earnings Call: Our Top 5 Analyst Questions - stockstory.org
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 285 (M) |
| Shares Float | 185 (M) |
| Held by Insiders | 2.2 (%) |
| Held by Institutions | 105.7 (%) |
| Shares Short | 12,120 (K) |
| Shares Short P.Month | 15,840 (K) |
| EPS | 0.56 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.32 |
| Profit Margin | 13.4 % |
| Operating Margin | 37.9 % |
| Return on Assets (ttm) | 8.6 % |
| Return on Equity (ttm) | 27.7 % |
| Qtrly Rev. Growth | 9.1 % |
| Gross Profit (p.s.) | 2.34 |
| Sales Per Share | 4.27 |
| EBITDA (p.s.) | 2.02 |
| Qtrly Earnings Growth | 569.5 % |
| Operating Cash Flow | 292 (M) |
| Levered Free Cash Flow | 154 (M) |
| PE Ratio | 32.85 |
| PEG Ratio | 1.3 |
| Price to Book value | 8.03 |
| Price to Sales | 4.38 |
| Price to Cash Flow | 18.29 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|